Archive

Ono Pharmaceutical Co., Ltd. (Osaka, Japan; Representative Director, President, Gyo Sagara; “ONO”) and 3H Clinical Trial Inc. (Tokyo, Japan; Representative Director, Hirotaka Takizawa; “3H”) announced that the companies developed and started providing “Fukusapo”, an adverse drug reaction (ADR) management supporting tool for patients as from today, aiming at the ADR management in patients receiving the […]

Clinical trial conduct is a substantial investment requiring the right mix of resources and time. With the pharmaceutical industry facing many challenges in the Western world due to escalating costs and challenges in meeting the recruitment and retention of subjects, there is a trend in navigating clinical trial options in the Asian continent. Contract research […]

Japan is rapidly moving into a society with a standardised digitalisation approach with modernised public services. This helps Japan to reinforce international competitiveness and also improves the convenience for Japanese citizens. This government led initiative towards digital transformation has helped in achieving a single administrative framework across Japan through the latest ‘Digital Agency’ initiative. Japan’s […]

Supporting clinical trial patients at home is getting popular choice today in Japan following this pandemic. The need for decentralized clinical trials in Japan has increased, as measures have been implemented to prevent the re-emergence of the outbreak and streamline the systems used to run clinical trials. Unless mandatory, clinical trial patients are served in […]

Background: Adaptive clinical trials bring in flexibility, efficiency and improves the satisfaction levels of clinical trial subjects. This ulcerative colitis study by 3H has been executed to enhance patient centricity. Ulcerative colitis, a rather less common medical condition has had limited clinical trials performed in the past. However, novel therapy is opening doors for improved treatment. […]

LOS ANGELES and TOKYO, October  27, 2021 — Science 37,  the Operating System for today’s more agile clinical trials and 3H Medi Solution Inc., a clinical trials solution leader in Japan today announced a collaboration to further decentralized clinical trials and accelerate the development of therapies. In this partnership, 3H Medi Solution will use Science […]

System integration between ePRO (electronic patient report outcome) and electronic medical record (EMR). Possibility to confirm data input from electronic medical record itself done on the cancer patient app. Improve the quality of medical care by utilizing ICT in line with the medical field. St. Marianna University School of Medicine (Kawasaki City, Kanagawa Prefecture, President: […]

Non-small cell lung cancer (NSCLC), which is a type of epithelial lung cancer is prevalent in Japan. The absolute number of newly reported cases and deaths in men and women have increased over the years. Building awareness about the trial is an important strategy for recruitment. It is important that not just patients with NSCLC […]

A recent study conducted to estimate the prevalence of depression among adolescents has shown that there is high prevalence. Results indicate that there is a 10% young population with depression which amounted to approximately 550,000 adolescents. These children were treated by psychiatrists using pharmacotherapy and indicates a growing need for having approved treatments in adolescents […]

South Korea has made a name in the clinical trial industry through its unprecedented growth in the industry during the past two decades. There has been several regulatory reforms, adoption of ICH-GCP and continuous investment by the government to enhance the standards and quality of clinical trial conduct to make the country a Global Centre […]